Rafferty Asset Management
DYN icon

Rafferty Asset Management’s Dyne Therapeutics DYN Stock Holding History

Rafferty Asset Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Sell
115,102
-67,875
-37% -$1.26M 0.01% 583
2026
Q1 		$3.32M Sell
182,977
-50,858
-22% -$877K 0.01% 500
2025
Q4 		$4.57M Buy
233,835
+20,624
+10% +$391K 0.02% 448
2025
Q3 		$2.7M Buy
213,211
+102,963
+93% +$1.17M 0.01% 571
2025
Q2 		$1.05M Sell
110,248
-37,105
-25% -$409K ﹤0.01% 756
2025
Q1 		$1.54M Sell
147,353
-20,129
-12% -$288K 0.01% 645
2024
Q4 		$3.95M Buy
167,482
+2,520
+2% +$74.5K 0.01% 461
2024
Q3 		$5.93M Buy
164,962
+19,584
+13% +$779K 0.02% 384
2024
Q2 		$5.13M Sell
145,378
-199,013
-58% -$5.78M 0.02% 408
2024
Q1 		$9.78M Buy
344,391
+180,350
+110% +$4.08M 0.04% 274
2023
Q4 		$2.18M Buy
164,041
+24,632
+18% +$241K 0.01% 649
2023
Q3 		$1.25M Buy
139,409
+22,145
+19% +$239K 0.01% 733
2023
Q2 		$1.32M Buy
+117,264
New +$1.38M 0.01% 747
2023
Q1 		– Sell
-14,191
Closed -$164K – 1150
2022
Q4 		$164K Sell
14,191
-6,937
-33% -$80.3K ﹤0.01% 1091
2022
Q3 		$268K Buy
+21,128
New +$242K ﹤0.01% 1029

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rafferty Asset Management's DYN Position: Q2 2026 in Review

Rafferty Asset Management reduced its Dyne Therapeutics (DYN) stake by 37% in Q2 2026, selling an estimated $1.26M and leaving 115,102 shares worth $2.56M. The position accounts for 0.01% of the portfolio, ranked #583.

Rafferty Asset Management first reported a position in DYN in Q3 2022 and has held it in 15 quarters since. The position peaked at $9.78M in Q1 2024. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Rafferty Asset Management held 115,102 shares of Dyne Therapeutics worth $2.56M as of Q2 2026.
  • Rafferty Asset Management sold 67,875 Dyne Therapeutics shares in Q2 2026, an estimated $1.26M.
  • Dyne Therapeutics made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #583 holding.
  • Rafferty Asset Management first reported a position in Dyne Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • Rafferty Asset Management's Dyne Therapeutics position peaked at $9.78M in Q1 2024.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.